Back to search

National and Kapodistrian University of Athens

Molecular analysis of psoriatic arthrιtis for determination of susceptibility, activity and response to treatment signatures

Abstract

dc:description

Psoriatic Arthritis (PsA) is a chronic, immune-mediated disease that affects up to one-third of patients with psoriasis (PsO) and manifests with skin and musculoskeletal inflammation. The introduction of biological disease-modifying anti-rheumatic drugs (bDMARDS) targeting T cells, cytokines of the TNFα and IL-12/-23 axis has led to a major improvement in the management of the disease, reflecting the crucial role of these cells and cytokines in PsA pathophysiology. However, a significant proportion of patients fail to respond optimally to these treatments. Diagnostic and prognostic biomarkers lack in PsA, and many aspects of the pathogenetic mechanism still need to be clarified. Gene expression studies, primarily conducted with microarray platforms, have provided an initial glimpse into the molecular heterogeneity of the disease. The transcriptional landscape remains, though still widely unexplored. In this study we conducted a comprehensive profiling of peripheral blood and skin fibroblasts “transcriptomic architecture” implementing high-throughput sequencing. Specifically, we performed longitudinal whole blood RNA-seq in 30 subjects with PsA at the beginning (baseline), one- and six-months after treatment, utilizing various bioinformatic tools to interpret our findings. We complemented our investigation with flow cytometry and deconvolution analysis to characterize the peripheral blood immune cell profile. Furthermore, in a subset of affected individuals and healthy controls, we performed RNA-seq on skin fibroblasts and conducted CellChat analysis to identify interactions between blood immune cells (periphery) and skin fibroblasts (target tissue). Our results revealed a distinct "activity" gene signature in peripheral blood in PsA, characterized by TNFα and IFN-driven inflammation, and dysregulated cholesterol and fatty acid metabolism. We also noticed an expansion of pro-inflammatory non-classical monocytes in patients with active disease. Comparison with the blood transcriptome of other conditions like rheumatoid arthritis (RA), PsO, and systemic lupus erythematosus (SLE) unveiled a "PsA-specific signature," particularly enriched in extracellular matrix remodeling. This observation was further supported by the gene expression profile of skin fibroblasts, which displayed an activated, proliferating phenotype, and by the skin-blood interactome analysis, revealing interactions with circulating immune cells via WNT and PDGF pathways, and immune-related semaphorins. We identified a molecular signature associated with treatment resistance, linked to aberrant TGFβ signaling and persistent elevation of non-classical monocytes. Conversely, early response to treatment was characterized by pro-inflammatory pathways related to platelet activation and Hippo signaling. Overall, our study provides novel insights into PsA's pathogenesis, emphasizing the potential role of stromal cells, and proposes molecular biomarkers with diagnostic and prognostic implications, laying the groundwork for a novel molecular stratification of PsA patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Grivas, Alexandros
  • Γρίβας, Αλέξανδρος

Subjects

dc:subject × 14

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57249

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Grivas, Alexandros; Γρίβας, Αλέξανδρος. Molecular analysis of psoriatic arthrιtis for determination of susceptibility, activity and response to treatment signatures. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/57249